Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Clinical Trials

Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

Clinical Trials
Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the first volunteers have been enrolled in the...

Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19

Clinical Trials
Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...

US doubles COVID vaccine fund as Moderna enters final phase of clinical trial

Clinical Trials
The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by American firm Moderna, which...

Heron Therapeutics initiates phase 2 GUARDS-1 study of Cinvanti to treat COVID-19

Clinical Trials
Heron Therapeutics, a commercial-stage biotechnology company, announced the initiation of the GUARDS-1 Study, a phase 2 clinical study evaluating Cinvanti (aprepitant) injectable emulsion in...

Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis

Clinical Trials
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key...

Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

Clinical Trials
Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This open-label study evaluated 5-day...

Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

Clinical Trials
Takeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the European Hematology Association (EHA)....

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.